Uso del instrumento FINDRISK para identificar el riesgo de prediabetes y diabetes mellitus tipo 2

Harold José Mariano Cantillo; Diego Fernando Ocampo; Karen Lucia Cuello Santana

doi:10.31260/RepertMedCir.v28.n3.2019.956

Use of the FINDRISK questionnaire for prediabetes and type 2 diabetes screening

Uso del instrumento FINDRISK para identificar el riesgo de prediabetes y diabetes mellitus tipo 2

Published 2019-10-25

Open | Download

PDF (Spanish) FLIP HTML (Spanish) EPUB (Spanish) XML (Spanish) AUDIO (mp3) (Spanish)

Issue

Vol. 28 No. 3 (2019): Septiembre - Diciembre

Section

Research Article

How to Cite

Mariano Cantillo, H. J., Ocampo, D. F., & Cuello Santana, K. L. (2019). Use of the FINDRISK questionnaire for prediabetes and type 2 diabetes screening. Journal of Medicine and Surgery Repertoire, 28(3), 157-163. https://doi.org/10.31260/RepertMedCir.v28.n3.2019.956

DOI

https://doi.org/10.31260/RepertMedCir.v28.n3.2019.956

Dimensions

PlumX

Citations

Citations in Crossref

Citations in Scopus

Citations in Europe PMC

license

Harold José Mariano Cantillo

Fundación Universitaria Ciencias de la Salud

Perfil Google Scholar

Diego Fernando Ocampo

Fundación Universitaria Ciencias de la Salud

Karen Lucia Cuello Santana

Fundación Universitaria Ciencias de la Salud

Perfil Google Scholar

Show authors biography

##plugins.themes.bootstrap3.displayStats.noStats##

diabetes mellitus

type 2/ diagnosis

type 2/- epidemiology

risk factors

prediabetes stage

validation studies

Objective: to determine the risk for developing type 2 diabetes mellitus and prediabetes using the FINDRISC questionnaire in patients aged between 35 and 75 years at the outpatient clinic. Methods: a descriptive cross-sectional analysis applying the FINDRISC questionnaire for Colombia. Patients with a FINDRISC score of 12 or higher were studied measuring glycemic markers and lipid profile. Univariate and bivariate data analysis was used, as well as multiple correspondences. Results: out of 796 participants 11% (n= 88) had prediabetes and 0.7% (n=6) had diabetes, 36.8% (n=293) had a FINDRISC score equal or greater than 12, of these, 30% were diagnosed with prediabetes and 2% with diabetes; 54.9% had associated hypertension, 50% had family history for diabetes, 43% history of dyslipidemia, 86% had a waist circumference greater than the established values and dyslipidemia was present in more than 50%. Conclusion: the FINDRISC questionnaire is a useful screening tool for prediabetes and diabetes, favoring early treatment and the prevention of complications. Additionally, those with glycemic disorders and a FINDRISC score greater or equal to 12 showed a tendency to have associated dyslipidemia, which indicate the need to perform a comprehensive metabolic panel.

Article visits 9973 | PDF visits 16560